Skip to main content

Neurology

RSS  

Articles

  • Pharmacology Update: Pregabalin Capsules (Lyrica™)

    Pregabalin has been approved for the management of neuropathic pain. It is the second drug to be approved for the treatment of painful diabetic neuropathy (after duloxetine) and the first drug to be approved for both diabetic neuropathy and postherpetic neuralgia.
  • Sugar is Sweet, but Snoring is Boring

    Sleep apnea can exacerbate diabetes, and Continuous Positive Airway Pressure (CPAP) can improve glucose control in diabetic patients with sleep apnea.
  • A Drink a Day for Women’s Mental Health

    Moderate consumption of alcohol in women (about 1 drink daily) was associated with better cognitive scores at 2-year average follow-up in women aged 70 to 81 in the Nurses Health Study compared to nondrinkers, while excessive drinkers did not show any association with either improvement or decline.
  • How Should We Manage Sub-Clinical Thyroid Disease?

    These studies note that: . . .sub-clinical thyroid dysfunction is a common clinical problem with many controversial issues regarding screening, evaluation, and management.
  • What’s the Correct BP to Reduce Adverse CV Events?

    Several classes of pharmacological agents have demonstrated benefits in hypertensive patients with CAD, but most published studies have, of necessity, enrolled only patients with an elevated or borderline elevated blood pressure. Recent clinical trials have demonstrated benefits for both angiotensin-converting enzyme inhibitors and calcium channel blockers (in patients with coronary artery disease with relatively normal or borderline elevated blood pressures.
  • Clinical Briefs

    Although we have recently enjoyed the FDA approval of two agents for treatment of diabetic peripheral neuropathic pain (duloxetine [Cymbalta], pregabalin [Lyrica]), as yet we have no treatment for diabetic peripheral neuropathy itself.
  • Full March 29, 2005, Issue in PDF

  • Death Notification and Grief Response in the Emergency Department

    An emergency physician often is the first and only health care provider that families interact with after a loved ones death. Yet emergency physicians often are uncomfortable and undertrained in delivering bad news. This is especially true when the death involves a child. Counseling families after a death needs to be performed properly and systematically to help manage the grief response of survivors. The emergency physician also must be well versed in the after care that is associated with a death in the emergency department, such as organ donation. This issue of Emergency Medicine Specialty Reports offers the means to provide an effective and compassionate death notification in a variety of circumstances.
  • Treating Hypertension in the Emergency Department: First, Do No Harm, Part I

    This issue of Emergency Medicine Reports reviews urgent and emergent hypertension syndromes encountered in the ED and approaches to patient assessment and pharmacologic management. Part I will cover the clinical evaluation of hypertensive patients and hypertension syndromes. Part II will discuss antihypertensive medications and the management of hypertension in specific disease processes.
  • Full March 21, 2005, Issue in PDF